首页> 外文会议>International Baltic Conference of Engineering Materials and Tribology >Cross-linked Dexamethasone Sodium Phosphate Delivery Systems Based on Silver Doped Hydroxyapatite Scaffolds
【24h】

Cross-linked Dexamethasone Sodium Phosphate Delivery Systems Based on Silver Doped Hydroxyapatite Scaffolds

机译:基于银掺杂羟基磷灰石支架的交联地塞米松磷酸钠递送系统

获取原文

摘要

One of the most used calcium phosphate implant materials in bone tissue regeneration is synthetic hydroxyapatite, which is similar to mineral phase of bone. By adding antibacterial effect to hydroxyapatite properties and creating controlled drug delivery systems based on this material, it is possible to obtain multifunctional material. Thus, in this study hydroxyapatite was doped with silver up to 1 wt% to provide antibacterial effect and from the obtained material dense and porous scaffolds were prepared. Prepared scaffolds were coated with chitosan and cross-linked with dexamethasone sodium phosphate (DEXA). Scaffolds were characterized and it is shown that linkage between chitosan coating and DEXA on the surface of hydroxyapatite and silver doped hydroxyapatite can ensure the controlled drug release up to 70 h.
机译:骨组织再生中最常用的磷酸钙植入材料之一是合成羟基磷灰石,其类似于骨骼的矿物阶段。通过向羟基磷灰石特性添加抗菌作用并基于该材料产生受控药物递送系统,可以获得多功能材料。因此,在本研究中,羟基磷灰石掺杂银,最高可达1wt%以提供抗菌作用,并从所得材料致密和多孔支架中制备。准备好的支架用壳聚糖涂覆并与地塞米松磷酸钠(Dexa)交联。表征了支架,表明壳聚糖涂层和甲磷酸盐表面上的甲状腺涂层和甲状腺磷灰石表面之间的连锁可以确保受控药物释放到70小时。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号